Anticancer effect of histone deacetylase inhibitor scriptaid as a single agent for hepatocellular carcinoma

Recurrence is one of the major causes of poor prognosis for patients with hepatocellular carcinoma (HCC), and drug resistance is closely associated with disease recurrence. Histone deacetylase (HDAC) inhibitor scriptaid functions as an anticancer agent in many different types of tumors, but its poss...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Linlin, Sun, Xiaoyang, Xie, Yu, Zhuang, Yinping, Yao, Ruosi, Xu, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043718/
https://www.ncbi.nlm.nih.gov/pubmed/29945926
http://dx.doi.org/10.1042/BSR20180360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043718/
https://www.ncbi.nlm.nih.gov/pubmed/29945926
http://dx.doi.org/10.1042/BSR20180360

Ejemplares similares